{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "facility-means", "type": "clause", "offset": [14, 28]}, {"key": "the-leased-property", "type": "clause", "offset": [176, 195]}, {"key": "construction-of-the", "type": "clause", "offset": [204, 223]}, {"key": "first-solar", "type": "definition", "offset": [253, 264]}, {"key": "support-structure", "type": "definition", "offset": [274, 291]}, {"key": "below-grade", "type": "definition", "offset": [305, 316]}, {"key": "rent-payment", "type": "definition", "offset": [409, 421]}], "size": 5, "snippet": "for the Solar Facility means the date on which Groundbreaking occurs. As used herein, \u201cGroundbreaking\u201d shall mean the earlier of (a) when earth is moved for the improvement of the Leased Property for the construction of the Solar Facility, (b) when the first Solar Facility support structure is installed below grade at the Leased Property, or (c) when Company elects to make the first annual Commercial Term rent payment in the amount set forth in Section 5.2(a). Movement of earth for evaluation of the Leased Property shall not be considered Groundbreaking and shall not cause the Commercialization Date to occur. Company shall notify Landowner promptly if and when the Commercialization Date occurs.", "samples": [{"hash": "64e0CXF3Gwr", "uri": "/contracts/64e0CXF3Gwr#commercialization-date", "label": "Solar Energy Lease Agreement", "score": 31.7646343622, "published": true}, {"hash": "ekL9wYrfsfW", "uri": "/contracts/ekL9wYrfsfW#commercialization-date", "label": "Solar Energy Lease Agreement", "score": 31.7084028217, "published": true}, {"hash": "20dWkH74fc3", "uri": "/contracts/20dWkH74fc3#commercialization-date", "label": "Solar Energy Lease Agreement", "score": 31.684440707, "published": true}], "hash": "372a473a967aa406f99f2af8436400c6", "id": 1}, {"snippet_links": [{"key": "date-of", "type": "clause", "offset": [54, 61]}, {"key": "first-commercial-sale", "type": "clause", "offset": [66, 87]}, {"key": "major-pharmaceutical-market", "type": "definition", "offset": [93, 120]}], "size": 4, "snippet": "means the earlier of (a) December 31, 2006 or (b) the date of the First Commercial Sale in a Major Pharmaceutical Market.", "samples": [{"hash": "h7s40R4uo20", "uri": "/contracts/h7s40R4uo20#commercialization-date", "label": "License and Collaboration Agreement (Myriad Genetics Inc)", "score": 21.0, "published": true}, {"hash": "ko8XEhP3HAA", "uri": "/contracts/ko8XEhP3HAA#commercialization-date", "label": "License Agreement (Myriad Genetics Inc)", "score": 18.0, "published": true}, {"hash": "fCV9zl0zOEi", "uri": "https://investor.myriad.com/static-files/b2436cea-64e7-4d29-bfb6-72c3f14686e1", "label": "investor.myriad.com", "score": 9.2395619439, "published": false}], "hash": "dad2e36bad56c83977c2b76b5b7851cb", "id": 2}, {"snippet_links": [{"key": "selected-compound", "type": "definition", "offset": [15, 32]}, {"key": "day-of", "type": "clause", "offset": [43, 49]}, {"key": "calendar-quarter", "type": "definition", "offset": [54, 70]}, {"key": "following-the", "type": "definition", "offset": [83, 96]}, {"key": "date-of", "type": "clause", "offset": [97, 104]}], "size": 4, "snippet": "means for each Selected Compound the first day of the calendar quarter immediately following the date of [\u2026***\u2026] such Selected Compound to be sold [\u2026***\u2026]", "samples": [{"hash": "g6g6TZ5MPDL", "uri": "/contracts/g6g6TZ5MPDL#commercialization-date", "label": "Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)", "score": 21.0876112252, "published": true}, {"hash": "gpSsWxqpHR5", "uri": "/contracts/gpSsWxqpHR5#commercialization-date", "label": "Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)", "score": 21.0, "published": true}], "hash": "f454b2977daee5d2ecec7c31a0e44584", "id": 3}, {"snippet_links": [{"key": "reference-to-a", "type": "definition", "offset": [12, 26]}, {"key": "in-existence", "type": "definition", "offset": [39, 51]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [52, 76]}, {"key": "with-regard-to", "type": "clause", "offset": [156, 170]}, {"key": "the-united-states", "type": "definition", "offset": [171, 188]}, {"key": "date-of", "type": "clause", "offset": [194, 201]}, {"key": "fda-approval", "type": "clause", "offset": [202, 214]}, {"key": "to-manufacture", "type": "definition", "offset": [215, 229]}, {"key": "manufacturing-facility", "type": "definition", "offset": [235, 257]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [258, 276]}, {"key": "but-excluding", "type": "clause", "offset": [285, 298]}, {"key": "the-european-union", "type": "clause", "offset": [338, 356]}, {"key": "acceptance-of-the", "type": "clause", "offset": [374, 391]}, {"key": "change-notification", "type": "clause", "offset": [392, 411]}, {"key": "notified-body", "type": "clause", "offset": [419, 432]}, {"key": "first-commercialization-date", "type": "definition", "offset": [505, 533]}], "size": 3, "snippet": "means, with reference to a CoSeal Unit in existence as of the Effective Date, the occurrence of either of the following events without regard to order: (a) with regard to the United States, the date of FDA approval to manufacture at a manufacturing facility by or on behalf of Baxter, but excluding an AAC facility, or (b) with regard to the European Union, the date of the acceptance of the change notification by the notified body. The first of these events to occur shall be referred to herein as the \u201cFirst Commercialization Date,\u201d and the second of these events to occur shall be referred to herein as the \u201cSecond Commercialization Date.\u201d", "samples": [{"hash": "aTC7zI8Pd0G", "uri": "/contracts/aTC7zI8Pd0G#commercialization-date", "label": "Manufacturing and Supply Agreement", "score": 31.340862423, "published": true}, {"hash": "cKxoIL1WVVI", "uri": "/contracts/cKxoIL1WVVI#commercialization-date", "label": "Manufacturing Agreement (Angiotech Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "hFdqtZOB29X", "uri": "/contracts/hFdqtZOB29X#commercialization-date", "label": "Manufacturing and Supply Agreement (Angiotech Pharmaceuticals Inc)", "score": 19.0, "published": true}], "hash": "fb046e8c6d8d366f202a7e4d0a403495", "id": 4}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [0, 15]}, {"key": "the-product", "type": "clause", "offset": [16, 27]}, {"key": "unaffiliated-third-party", "type": "definition", "offset": [100, 124]}, {"key": "in-the-territory", "type": "clause", "offset": [125, 141]}], "size": 2, "snippet": "with respect to the Product, shall mean the date on which the Product is first sold by Dexcel to an unaffiliated Third Party in the Territory (\u201cLaunch\u201d).", "samples": [{"hash": "b2KENnaJg6K", "uri": "/contracts/b2KENnaJg6K#commercialization-date", "label": "Supply & Distribution Agreement (Elite Pharmaceuticals Inc /Nv/)", "score": 33.4900752909, "published": true}, {"hash": "cP668IvIhHI", "uri": "https://www.annualreports.com/HostedData/AnnualReportArchive/e/OTC_ELTP_2022.pdf", "label": "www.annualreports.com", "score": 11.2450376454, "published": false}], "hash": "b4cea7cbfb7666dbe9f5908fb0dec87d", "id": 5}, {"snippet_links": [{"key": "customer-for", "type": "clause", "offset": [52, 64]}, {"key": "days-after", "type": "definition", "offset": [129, 139]}, {"key": "licensed-products", "type": "definition", "offset": [211, 228]}, {"key": "by-licensee", "type": "clause", "offset": [239, 250]}, {"key": "in-accordance-with", "type": "definition", "offset": [251, 269]}, {"key": "the-specifications", "type": "clause", "offset": [412, 430]}, {"key": "approved-containers", "type": "clause", "offset": [439, 458]}, {"key": "of-licensee", "type": "clause", "offset": [531, 542]}, {"key": "withdrawal-procedures", "type": "clause", "offset": [556, 577]}, {"key": "consumer-inquiries", "type": "definition", "offset": [665, 683]}, {"key": "certificates-of-insurance", "type": "clause", "offset": [762, 787]}], "size": 2, "snippet": "means the date on which LICENSEE first invoices any customer for any LICENSED PRODUCT, which shall not be later than thirty (30) days after LICENSOR has approved the last of (a) labeling for each of the initial LICENSED PRODUCTS submitted by LICENSEE in accordance with clause 2.3, (b) the RECIPE INFORMATION for each of the initial LICENSED PRODUCTS submitted by LICENSEE in accordance with clause 12.1(a), (c) the specifications for the APPROVED CONTAINERS submitted by LICENSEE in accordance with clause 12.6, (d) the statement of LICENSEE\u2019s recall and withdrawal procedures submitted by LICENSEE in accordance with clause 12.11, (e) the statement of LICENSEE\u2019s Consumer Inquiries procedures submitted by LICENSEE in accordance with clause 12.13, and (f) the certificates of insurance submitted by LICENSEE in accordance with clause 14.2.", "samples": [{"hash": "4UNUnKwAAcN", "uri": "https://www.sec.gov/Archives/edgar/data/1414953/000114420412046690/v321855_ex10-1.htm", "label": "License Agreement (Mojo Organics, Inc.)", "score": 11.6255989049, "published": false}, {"hash": "48CkqbbWs1U", "uri": "https://www.sec.gov/Archives/edgar/data/1414953/000121390013000569/f8k081512a1ex10i_mojoorg.htm", "label": "Mojo Organics, Inc.", "score": 8.1019849418, "published": false}], "hash": "ac759f47d230d727956afcf527899894", "id": 6}, {"snippet_links": [{"key": "date-of", "type": "clause", "offset": [10, 17]}, {"key": "sale-of", "type": "clause", "offset": [39, 46]}, {"key": "major-market", "type": "definition", "offset": [62, 74]}, {"key": "following-regulatory-approval", "type": "clause", "offset": [75, 104]}], "size": 2, "snippet": "means the date of the first commercial sale of a Product in a Major Market following Regulatory Approval.", "samples": [{"hash": "lKywaP3P70e", "uri": "/contracts/lKywaP3P70e#commercialization-date", "label": "Confidential Agreement (Chiron Corp)", "score": 18.0, "published": true}, {"hash": "4UtrOu4979K", "uri": "/contracts/4UtrOu4979K#commercialization-date", "label": "Confidentiality Agreement (Chiron Corp)", "score": 18.0, "published": true}], "hash": "9e9bcf4eec0081bb3e308e4aad509529", "id": 7}, {"snippet_links": [{"key": "bona-fide", "type": "definition", "offset": [96, 105]}, {"key": "of-the-purchaser", "type": "clause", "offset": [140, 156]}, {"key": "cumulative-basis", "type": "clause", "offset": [174, 190]}, {"key": "during-the-period", "type": "clause", "offset": [191, 208]}, {"key": "following-the-closing", "type": "clause", "offset": [209, 230]}], "size": 1, "snippet": "means the date on which Purchaser has sold its five hundredth (500th) unit of Solos Products to bona fide customers that are not Affiliates of the Purchaser (determined on a cumulative basis during the period following the Closing).", "samples": [{"hash": "kw7eFNie896", "uri": "/contracts/kw7eFNie896#commercialization-date", "label": "Asset Purchase Agreement (Kopin Corp)", "score": 31.1902806297, "published": true}], "hash": "4939cc2639912a9917267c00ba4ffdc3", "id": 8}, {"snippet_links": [{"key": "facility-means", "type": "clause", "offset": [14, 28]}, {"key": "the-property", "type": "clause", "offset": [47, 59]}, {"key": "development-of-the", "type": "clause", "offset": [68, 86]}], "size": 1, "snippet": "for the Solar Facility means groundbreaking on the Property for the development of the Solar Facility. CES shall notify Landowner promptly if and when the Commercialization Date occurs.", "samples": [{"hash": "3a184l0SnHY", "uri": "/contracts/3a184l0SnHY#commercialization-date", "label": "Solar Farm Site Interim Control Agreement", "score": 22.0989735476, "published": true}], "hash": "639b4cb6abe38bb2fe3d52bb01a7c81a", "id": 9}, {"snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [70, 88]}, {"key": "this-agreement", "type": "clause", "offset": [99, 113]}], "size": 1, "snippet": "means the date upon which Commercialization has occurred as specially defined in Section 6.1(a) of this Agreement.", "samples": [{"hash": "2L7ZusuECh7", "uri": "/contracts/2L7ZusuECh7#commercialization-date", "label": "Exclusive Distribution Agreement (Macropore Inc)", "score": 21.0, "published": true}], "hash": "70e3ec4b3e7f983106a7289c629d4cba", "id": 10}], "next_curs": "CmMSXWoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIfY29tbWVyY2lhbGl6YXRpb24tZGF0ZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 37, "snippet": "for the Solar Facility means the date on which Groundbreaking occurs. As used herein, \u201cGroundbreaking\u201d shall mean the earlier of (a) when earth is moved for the improvement of the Leased Property for the construction of the Solar Facility, (b) when the first Solar Facility support structure is installed below grade at the Leased Property, or (c) when Company elects to make the first annual Commercial Term rent payment in the amount set forth in Section 5.2(a). Movement of earth for evaluation of the Leased Property shall not be considered Groundbreaking and shall not cause the Commercialization Date to occur. Company shall notify Landowner promptly if and when the Commercialization Date occurs.", "title": "Commercialization Date", "id": "commercialization-date", "examples": ["The Commercial Term Rent for the first year of the Commercial Term shall be due on or before the <strong>Commercialization Date</strong>.", "No later than the <strong>Commercialization Date</strong>, and for the remaining duration of the Commercial Term (as it may be extended), Company shall post or arrange for the posting of security funds in a manner and amount sufficient to ensure decommissioning of the Solar Facility and removal of the Solar Facility Equipment from the Leased Property consistent with the Decommissioning Cost Estimate, as it may be updated (\u201cDecommissioning Security\u201d).", "Company shall notify Landowner promptly if and when the <strong>Commercialization Date</strong> occurs.", "Movement of earth for evaluation of the Leased Property shall not be considered Groundbreaking and shall not cause the <strong>Commercialization Date</strong> to occur.", "If, as of the <strong>Commercialization Date</strong> for a Product, either Party in good faith reasonably believes that the Initial Price for the Product is not economically feasible to achieve the Party\u2019s business objectives for commercialization of the Product, that Party shall notify the other Party in writing.", "No more than 90 days in advance of the <strong>Commercialization Date</strong>, Company shall provide to Landowner an estimate of the cost, calculated by a reputable, mutually agreed upon third-party engineer not associated with the engineer or engineering firm that prepared the site plan or construction plans for the Solar Facility, for the removal of the Solar Facility Equipment from the Leased Property and the restoration of the soil surface of the Leased Property (the \u201cDecommissioning Cost Estimate\u201d).", "For each subsequent year of the Commercial Term, Company shall pay to Landowner Commercial Term Rent equal to the prior year\u2019s Commercial Term Rent increased by The Commercial Term Rent for each subsequent year of the Commercial Term, as it may be extended, shall be due on or before each anniversary of the <strong>Commercialization Date</strong>.", "Associate Vice President for Research and Director, Office of Technology <strong>Commercialization Date</strong> 1/30/17 LICENSEE: Aeglea BioTherapeutics, Inc.", "If the <strong>Commercialization Date</strong> does not occur prior to expiration of the Development Feasibility Term (as it may be extended), this Lease shall terminate.", "Thereafter, until the Second <strong>Commercialization Date</strong>, \u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 sole legal remedy for AAC\u2019s failure to provide a given CoSeal Unit(s) according to the Forecast shall be either suspension of \u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 Minimum Sales requirements for the given CoSeal Unit(s) for that calendar year, or a downward adjustment of \u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 Minimum Sales requirements for the given CoSeal Unit(s) for that calendar year that is equal to the sales that would be attributable to the given CoSeal Unit(s) that AAC failed to provide."], "related": [["commercialization", "Commercialization", "Commercialization"], ["commercialization-plan", "Commercialization Plan", "Commercialization Plan"], ["development-period", "Development Period", "Development Period"], ["collaboration-product", "Collaboration Product", "Collaboration Product"], ["research-program-term", "Research Program Term", "Research Program Term"]], "related_snippets": [], "updated": "2025-07-06T21:56:40+00:00"}, "json": true, "cursor": ""}}